✔️#UroAktuell: Sind Sie schon angemeldet? Noch bis 15. April 2022 kann der Frühbucherrabatt genutzt werden ‼️ #dgu22 solution-akademie-veranstaltungen.de/uroaktuell BvDUrologie GeSRU Academics GeSRU UroEvidence Association Française d'Urologie - AFU Axel S. Merseburger Christian Wülfing @DocMeetings - Urology Uronauten TnT Aegnor

We’re happy to announce that the PIONEER #BigData platform is growing: A new data sharing agreement has been signed with @Prof. Gratzke from Universität Freiburg. More info will follow soon. BD4BO @IMI_JU

Seminar des Arbeitskreises Urologische Funktionsdiagnostik und Urologie der Frau mit spannenden Themen zur funktionellen Urologie in der kommenden Woche in Berlin. Anmeldung unter: solution-akademie-veranstaltungen.de/uroaktuell

Current Issue: Long-term Clinical Outcomes of Repeat Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: A Case Series buff.ly/3OjN5px Markus Grabbert August Sigle Constantinos Zamboglou Christian Gratzke #clinicaloutcomes #urology

Novel bladder immune performance index (BIPI) developed by using a combined real world clinico-genomic database. RWD can support future clinical trial designs and may lead to innovative new treatment approaches. #imFLAME #imCORE

New Platinum Priority Editorial from Tanya Dorff Alicia Morgans, MD, MPH A Path to Precision Medicine in Prostate Cancer: Learning from “Negative” Trials of Targeted Therapies buff.ly/3Q6FsDV

To all young urologists out there - the answer to the question "who do you want to be like when your grow up" should be Christian Gratzke! Too many good things to say in 280 characters about what Christian is doing in the Urologische Klinik Uniklinik Freiburg. Thanks for memorable visit!

Today we treated our first patient within the #HypoFocal-SBRT trial Radiation Oncology University Freiburg. Great collective efforts by the whole team Uniklinik Freiburg Anca-L. Grosu, MD Constantinos Zamboglou Simon Spohn . We can’t wait for the other Centers to join in!!!🙌🙌 Deutsche Gesellschaft für Radioonkologie e.V. #radonc

Check out our paper by Simon Kirste, Alexander Rühle, Anca-L. Grosu, MD, Simon Lo and others from Uniklinik Freiburg ▶️1st prospective study about #SBRT for RCC in VHL pts ▶️Median f/u 43 mo ▶️2-year LC 100% ▶️2-year OS 85.7% ▶️No grade ≥2 tox mdpi.com/1888422 #radonc

#ASTRO2022 has been packed with loads of great contributions. Here are some of the highlights: ➡️ 7 years outcomes of the phase 3 PCS5 trial: MHRT of 68 Gy in 25 fx is non-inferior to 76 Gy in 38 fx in high risk PCa patients. 7 year BCR 87% (MHRT) vs 85% (NFRT). Dr. Tamim Niazi

Die Urologische Klinik des Universitätsklinikum Freiburg bedankt sich bei allen Mitarbeiter:innen und Kooperationspartner:innen für die gute Zusammenarbeit im vergangenen Jahr. Frohe Weihnachten! lnkd.in/e9HJn69S

UroToday.com Uniklinik Freiburg ASCO Christopher Wallis (he/him/his) University of Toronto Great team effort showing the strength of interdisciplinary research! PSMA-PET is entering nomograms for salvage RT. Nina Schmidt-Hegemann Simon Spohn Louise Emmett Andrea Farolfi prof. Stefano Fanti LMU Radiation Oncology Matthias Guckenberger Anca-L. Grosu, MD くま German Oncology Center #GU23

#ASCO23 SWOG Cancer Research Network S1011: With radical cystectomy for muscle invasive #bladdercancer, extended lymphadenectomy is not assoc w improved DFS or OS compared to standard node dissection splernerMD oral pres Mon, June 5, 1:54 pm, Hall D1 Bladder Cancer Advocacy Network #blcsm swog.org/news-events/ne…

#ASCO23 ASCO Toni Choueiri, MD present the data on Contact-3 trial which addresses a major question in the #mRCC #kidneycancer field 👉Is there a role of ICI Re-challenge? Answer is “NO”. This study does change my practice in many patients. Congrats for the simultaneous @theLancet

Neoadjuvant atezo in non-urothelial cancer subtypes led by Bernadett Szabados Barts Experimental Cancer Medicine Centre #ESMO23 . Firstly, the inconsistency in pathology review is problematic. Secondly, the responders in the sarcomatoid group was very high - as in renal cancer. These patients need IO at some point.

💫🌟Disappointing update from #ESMO23: Dr. Christina Gratzke reveals KEYNOTE-991 study results, emphasizing the complexities of treating metastatic hormone-sensitive prostate cancer (mHSPC). Here's what we've learned: 🔵 KEYNOTE-991 Study Insights: - Study halted: Pembro + Enza

A monumental moment for bladder cancer today. A privilege to have worked on this trial which will change the landscape of bladder cancer. 👏🏻

#EAU #AUA exchange program with wonderful Kristen R. Scarpato Boyd Viers at Uniklinik Freiburg, having dinner with our friends from European Association of Urology (EAU) guidelines member Gernot Bonkat and Eur Urol Focus ass. editor Malte Rieken in #Basel - what an experience! Amer. Urol. Assn. European Association of Urology (EAU) Markus Grabbert

The fantastic European Association of Urology (EAU) Amer. Urol. Assn. exchange continues in #Freiburg with the great Christian Gratzke ! So many wonderful experiences that I will cherish forever. Grateful for new friends and collaborators! Malte Rieken Markus Grabbert Gernot Bonkat Boyd Viers August Sigle

Join us for the Radiation Therapy in Prostate Cancer Symposium in Freiburg on the 19th-20th of July 2024, meet international experts in uro-oncology and present your own research in the poster session. Programm and registration via uniklinik-freiburg.de/prostate-cance… Accredited by Deutsche Gesellschaft für Radioonkologie e.V.